Man­u­fac­tur­ing roundup: Eu­roAPI to in­vest $50M+ in Hun­gary site; WuXi to ex­pand Ger­man fa­cil­i­ty

Ac­tive phar­ma­ceu­ti­cal in­gre­di­ent man­u­fac­tur­er Eu­roAPI is look­ing to make a €50 mil­lion ($53.4 mil­lion) in­vest­ment in­to boost­ing pro­duc­tion at its fa­cil­i­ty in Bu­dapest, Hun­gary.

Ac­cord­ing to a re­lease, Eu­roAPI’s ex­pan­sion plans to “de­bot­tle­neck” the pro­duc­tion at the fa­cil­i­ty along with dou­bling the fa­cil­i­ty’s out­put of prostaglandin by 2027. Prostaglandin is a lipid used in the pro­duc­tion of APIs. The project al­so aims to bol­ster the man­u­fac­tur­er’s op­er­a­tions in Hun­gary.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.